Cargando…
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
Targetable alterations in cancer offer novel opportunities to the drug discovery process. However, pre-clinical testing often requires solubilization of these drugs in cosolvents like dimethyl sulfoxide (DMSO). Using a panel of cell lines commonly used for in vitro drug screening and pre-clinical te...
Autores principales: | Baldelli, Elisa, Subramanian, Mahalakshmi, Alsubaie, Abduljalil M., Oldaker, Guy, Emelianenko, Maria, El Gazzah, Emna, Baglivo, Sara, Hodge, Kimberley A., Bianconi, Fortunato, Ludovini, Vienna, Crino’, Lucio, Petricoin, Emanuel F., Pierobon, Mariaelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001778/ https://www.ncbi.nlm.nih.gov/pubmed/33802212 http://dx.doi.org/10.3390/ijms22062819 |
Ejemplares similares
-
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021) -
Erratum to: ‘Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology’
por: Bianconi, Fortunato, et al.
Publicado: (2016) -
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study
por: Ludovini, Vienna, et al.
Publicado: (2017) -
Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology
por: Bianconi, Fortunato, et al.
Publicado: (2015) -
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
por: Baldelli, Elisa, et al.
Publicado: (2015)